CRBU
Price
$1.57
Change
-$0.06 (-3.68%)
Updated
Jul 24 closing price
Capitalization
155.71M
18 days until earnings call
Intraday BUY SELL Signals
IKT
Price
$2.33
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Capitalization
365.89M
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs IKT

CRBU vs IKT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRBU vs. IKT commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a StrongBuy and IKT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2026
Stock price -- (CRBU: $1.57 vs. IKT: $2.33)
Brand notoriety: CRBU and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 32% vs. IKT: 189%
Market capitalization -- CRBU: $155.71M vs. IKT: $365.89M
CRBU [@Biotechnology] is valued at $155.71M. IKT’s [@Biotechnology] market capitalization is $365.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileIKT’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • IKT’s FA Score: 0 green, 5 red.
According to our system of comparison, IKT is a better buy in the long-term than CRBU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 3 TA indicator(s) are bullish while IKT’s TA Score has 5 bullish TA indicator(s).

  • CRBU’s TA Score: 3 bullish, 7 bearish.
  • IKT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IKT is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -4.85% price change this week, while IKT (@Biotechnology) price change was +10.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.78%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +1901.89%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2026.

IKT is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Biotechnology (-4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IKT($366M) has a higher market cap than CRBU($156M). IKT YTD gains are higher at: 13.659 vs. CRBU (-1.258). IKT has higher annual earnings (EBITDA): -55.75M vs. CRBU (-116.43M). IKT has more cash in the bank: 170M vs. CRBU (118M). IKT has less debt than CRBU: IKT (0) vs CRBU (26.9M). CRBU has higher revenues than IKT: CRBU (11.2M) vs IKT (0).
CRBUIKTCRBU / IKT
Capitalization156M366M43%
EBITDA-116.43M-55.75M209%
Gain YTD-1.25813.659-9%
P/E RatioN/A3.47-
Revenue11.2M0-
Total Cash118M170M69%
Total Debt26.9M0-
TECHNICAL ANALYSIS
Technical Analysis
CRBUIKT
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 5 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
IKT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BREFX40.770.77
+1.93%
Baron Real Estate Retail
AVLVX19.690.07
+0.36%
Avantis U.S. Large Cap Value Inst
PASSX63.92N/A
N/A
T. Rowe Price Small-Cap Stock Adv
TSFIX17.10N/A
N/A
Touchstone Small Cap Institutional
WCMWX25.51N/A
N/A
WCM Focused Emerging Mkts Ex Chn Inst

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with EDIT. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-3.68%
EDIT - CRBU
65%
Loosely correlated
-4.76%
CRSP - CRBU
55%
Loosely correlated
-2.08%
SANA - CRBU
53%
Loosely correlated
-0.93%
RXRX - CRBU
52%
Loosely correlated
-1.66%
BEAM - CRBU
51%
Loosely correlated
-3.13%
More

IKT and

Correlation & Price change

A.I.dvisor tells us that IKT and VIR have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IKT and VIR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
N/A
VIR - IKT
33%
Poorly correlated
-6.96%
CRBU - IKT
33%
Poorly correlated
-3.68%
BNTC - IKT
32%
Poorly correlated
+0.26%
GNLX - IKT
32%
Poorly correlated
-2.36%
EDIT - IKT
32%
Poorly correlated
-4.76%
More